Pericyte antigens in perivascular soft tissue tumors

International Journal of Surgical Pathology

Volumn 23, Issue 8, 2015, Pages 638-648

  Shen, Jia ^a   Shrestha, Swati ^a   Yen, Yu Hsin ^a   Asatrian, Greg ^a   Mravic, Marco ^a   Soo, Chia ^a   Ting, Kang ^a   Dry, Sarah M ^a   Peault, Bruno ^a,b   James, Aaron W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

angioleiomyoma; CD146; glomus tumor; hemangiopericytoma; Mel CAM; myopericytoma; PDGFRB; pericyte; platelet derived growth factor receptor; solitary fibrous tumor

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALDESMON; CD146 ANTIGEN; CD31 ANTIGEN; CD34 ANTIGEN; DESMIN; KERATIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; PROTEIN S 100; TRANSCRIPTION FACTOR SOX10; TUMOR ANTIGEN; TUMOR MARKER;

ARTICLE; CELL DIFFERENTIATION; GLOMUS TUMOR; HEMANGIOPERICYTOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LEIOMYOMA; MYOPERICYTOMA; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE TUMOR; SOLITARY FIBROUS TUMOR; TUMOR VOLUME; VASCULAR TUMOR; BIOSYNTHESIS; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY;

ANTIGENS, NEOPLASM; BIOMARKERS, TUMOR; HUMANS; IMMUNOHISTOCHEMISTRY; PERICYTES; RETROSPECTIVE STUDIES; SOFT TISSUE NEOPLASMS;

EID: 84947429205     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896915591272     Document Type: Article

References (46)

1. Weiss SW, Goldblum JJ., Enzinger and Weiss's Soft Tissue Tumors. Philadelphia, PA: Mosby Elsevier; 2008.
2. Mosquera JM, Sboner A, Zhang L, et al. Novel MIR143-NOTCH fusions in benign and malignant glomus tumors. Genes Chromosomes Cancer. 2013; 52: 1075-1087.
3. Mentzel T, Dei Tos AP, Sapi Z, Kutzner H., Myopericytoma of skin and soft tissues: clinicopathologic and immunohistochemical study of 54 cases. Am J Surg Pathol. 2006; 30: 104-113.
4. Granter SR, Badizadegan K, Fletcher CD., Myofibromatosis in adults, glomangiopericytoma, and myopericytoma: a spectrum of tumors showing perivascular myoid differentiation. Am J Surg Pathol. 1998; 22: 513-525.
5. Faggioli GL, Bertoni F, Stella A, Bacchini P, Mirelli M, Gessaroli M., Multifocal diffuse glomus tumor. A case report of glomangiomyoma and review of the literature. Int Angiol. 1988; 7: 281-286.
6. Porter PL, Bigler SA, McNutt M, Gown AM., The immunophenotype of hemangiopericytomas and glomus tumors, with special reference to muscle protein expression: an immunohistochemical study and review of the literature. Mod Pathol. 1991; 4: 46-52.
7. Matsuyama A, Hisaoka M, Hashimoto H., Angioleiomyoma: a clinicopathologic and immunohistochemical reappraisal with special reference to the correlation with myopericytoma. Hum Pathol. 2007; 38: 645-651.
8. Corselli M, Chen CW, Sun B, Yap S, Rubin JP, Peault B., The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells. Stem Cells Dev. 2012; 21: 1299-1308.
9. Murray IR, West CC, Hardy WR, et al. Natural history of mesenchymal stem cells, from vessel walls to culture vessels. Cell Mol Life Sci. 2014; 71: 1353-1374.
10. Watanabe K, Kusakabe T, Hoshi N, Saito A, Suzuki T., h-Caldesmon in leiomyosarcoma and tumors with smooth muscle cell-like differentiation: its specific expression in the smooth muscle cell tumor. Hum Pathol. 1999; 30: 392-396.
11. Köhler CN., Histochemical localization of caldesmon in the CNS and ganglia of the mouse. J Histochem Cytochem. 2011; 59: 504-517.
12. Miettinen M, Lehto VP, Virtanen I., Glomus tumor cells: evaluation of smooth muscle and endothelial cell properties. Virchows Arch B Cell Pathol Incl Mol Pathol. 1983; 43: 139-149.
13. Schurch W, Skalli O, Lagace R, Seemayer TA, Gabbiani G,. Intermediate filament proteins and actin isoforms as markers for soft-tissue tumor differentiation and origin. III. Hemangiopericytomas and glomus tumors. Am J Pathol. 1990; 136: 771-786.
14. Gombos Z, Zhang PJ., Glomus tumor. Arch Pathol Lab Med. 2008; 132: 1448-1452.
15. Harris M., Ultrastructure of a glomus tumour. J Clin Pathol. 1971; 24: 520-523.
16. Murad TM, von Haam E, Murthy MS., Ultrastructure of a hemangiopericytoma and a glomus tumor. Cancer. 1968; 22: 1239-1249.
17. Tsuneyoshi M, Enjoji M., Glomus tumor: a clinicopathologic and electron microscopic study. Cancer. 1982; 50: 1601-1607.
18. Diaz-Flores L, Gutierrez R, Garcia MP, Alvarez-Arguelles H, Diaz-Flores L Jr, Madrid JF., Myopericytoma and arterial intimal thickening: the relationship between myopericytes and myointimal cells. J Cutan Pathol. 2011; 38: 857-864.
19. Seifert HW., Ultrastructural investigation on cutaneous angioleiomyoma. Arch Dermatol Res. 1981; 271: 91-99.
20. Goldblum JR, Folpe AL, Weiss SW, Enzinger FM, Weiss SW., Enzinger and Weiss's Soft Tissue Tumors. 6th ed. Philadelphia, PA: Saunders/Elsevier; 2014.
21. Folpe AL, Fanburg-Smith JC, Miettinen M, Weiss SW., Atypical and malignant glomus tumors: analysis of 52 cases, with a proposal for the reclassification of glomus tumors. Am J Surg Pathol. 2001; 25: 1-12.
22. Trere D, Montanaro L, Ceccarelli C, et al. Prognostic relevance of a novel semiquantitative classification of Bcl2 immunohistochemical expression in human infiltrating ductal carcinomas of the breast. Ann Oncol. 2007; 18: 1004-1014.
23. Crisan M, Yap S, Casteilla L, et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell. 2008; 3: 301-313.
24. Shih IM, Nesbit M, Herlyn M, Kurman RJ., A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissue. Mod Pathol. 1998; 11: 1098-1106.
25. Palman C, Bowen-Pope DF, Brooks JJ., Platelet-derived growth factor receptor (beta-subunit) immunoreactivity in soft tissue tumors. Lab Invest. 1992; 66: 108-115.
26. Ozerdem U., Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer. Prostate. 2006; 66: 294-304.
27. Ozerdem U., Targeting neovascular pericytes in neurofibromatosis type 1. Angiogenesis. 2004; 7: 307-311.
28. Bondjers C, Kalen M, Hellstrom M, et al. Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol. 2003; 162: 721-729.
29. Cho H, Kozasa T, Bondjers C, Betsholtz C, Kehrl JH., Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J. 2003; 17: 440-442.
30. Wakui S, Yokoo K, Muto T, et al. Localization of Ang-1, -2, Tie-2, and VEGF expression at endothelial-pericyte interdigitation in rat angiogenesis. Lab Invest. 2006; 86: 1172-1184.
31. Alliot F, Rutin J, Leenen PJ, Pessac B., Pericytes and periendothelial cells of brain parenchyma vessels co-express aminopeptidase N, aminopeptidase A, and nestin. J Neurosci Res. 1999; 58: 367-378.
32. Klein D, Meissner N, Kleff V, et al. Nestin(+) tissue-resident multipotent stem cells contribute to tumor progression by differentiating into pericytes and smooth muscle cells resulting in blood vessel remodeling. Front Oncol. 2014; 4: 169.
33. Chen CW, Montelatici E, Crisan M, et al. Perivascular multi-lineage progenitor cells in human organs: regenerative units, cytokine sources or both? Cytokine Growth Factor Rev. 2009; 20: 429-434.
34. Chen CW, Okada M, Proto JD, et al. Human pericytes for ischemic heart repair. Stem Cells. 2013; 31: 305-316.
35. Corselli M, Chen CW, Crisan M, Lazzari L, Peault B., Perivascular ancestors of adult multipotent stem cells. Arterioscler Thromb Vasc Biol. 2010; 30: 1104-1109.
36. Crisan M, Chen CW, Corselli M, Andriolo G, Lazzari L, Peault B., Perivascular multipotent progenitor cells in human organs. Ann N Y Acad Sci. 2009; 1176: 118-123.
37. Crisan M, Deasy B, Gavina M, et al. Purification and long-term culture of multipotent progenitor cells affiliated with the walls of human blood vessels: myoendothelial cells and pericytes. Methods Cell Biol. 2008; 86: 295-309.
38. Crisan M, Huard J, Zheng B, et al. Purification and culture of human blood vessel-associated progenitor cells. Curr Protoc Stem Cell Biol. 2008;Chapter 2:Unit 2B 2 1-2B 2 13. doi: 10.1002/9780470151808.sc02b02s4.
39. Tang W, Zeve D, Suh JM, et al. White fat progenitor cells reside in the adipose vasculature. Science. 2008; 322: 583-586.
40. Mravic M, Asatrian G, Soo C, et al. From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering. Int Orthop. 2014; 38: 1819-1824.
41. Erlandson R., Diagnostic Transmission Electron Microscopy of Tumors. New York, NY: Raven Press; 1994.
42. Ghadially FN., Diagnostic Electron Microscopy of Tumours. London, England: Butterworth; 1980.
43. Nemes Z., Differentiation markers in hemangiopericytoma. Cancer. 1992; 69: 133-140.
44. Yamada Y, Kohashi K, Fushimi F, et al. Activation of the Akt-mTOR pathway and receptor tyrosine kinase in patients with solitary fibrous tumors. Cancer. 2014; 120: 864-876.
45. Stacchiotti S, Negri T, Libertini M, et al. Sunitinib malate in solitary fibrous tumor (SFT). Ann Oncol. 2012; 23: 3171-3179.
46. Stacchiotti S, Negri T, Palassini E, et al. Sunitinib malate and figitumumab in solitary fibrous tumor: patterns and molecular bases of tumor response. Mol Cancer Ther. 2010; 9: 1286-1297.